• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Genentech

Bicycle bike ride travel
Biotech

Bicycle lays off staff as Genentech rides away from R&D pact

The layoffs, which are part of a push to cut spending by 30%, follow Genentech’s termination of an oncology collaboration with the biotech.
Nick Paul Taylor Aug 8, 2025 8:50am
layoffs cut staff reduction workforce

Genentech cuts 87 more jobs in another round of HQ layoffs

Jul 23, 2025 10:33am
layoffs cut staff reduction workforce

Genentech lays off 143 workers at South San Francisco campus

Jun 11, 2025 12:25pm
glue scissors art supplies

Genentech sticks 2nd molecular glue deal with Orionis worth $2B

May 21, 2025 8:30am
GPS navigation to pins and multiple markers on route

Genentech builds autoimmune Repertoire with $765M deal

Apr 23, 2025 7:00am
Roche

Roche's $50B US investment to include upcoming Boston CVRM site

Apr 22, 2025 5:10am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings